Chargement des cours...
Prévisions
Aucune donnée d'analyste n'est disponible pour cette entreprise.
Actualités Accéder au fil d'actualités
NewGenIVF starts share buyback program of $2 million
NewGenIVF has begun implementing an authorized share buyback program totaling $2 million, to be carried out on the open market through The Benchmark Company, LLC (StoneX Group). Management says the move reflects their view that the market does not fully recognize the company’s value and progress; the stock recently posted a one‑week performance of +40.88% and shows a very low price‑to‑book ratio of 0.03 according to InvestingPro. The program does not commit to a minimum number of shares, may be adjusted depending on market conditions, and will comply with applicable securities regulations. » Plus sur de.investing.com
NewGenIVF converts Ras Al Khaimah luxury project into joint-development
NewGenIVF restructures the Beach District project in Ras Al Khaimah from a joint venture into a joint-development structure, with NewGenProperty set to assume full project financing. A feasibility study raises NewGen’s estimated pre-tax profit entitlement to USD 123m (64% of net profit), while BNW retains 36% of net profit for development services. The company plans to raise capital to finance the conversion, will start presales after meeting escrow requirements, and targets project completion in 2028; NewGenIVF also announced a USD 2m share buyback program and several tokenization and reverse-merger initiatives. » Plus sur de.investing.com
Données financières de l'entreprise
| (EUR) | déc. 2025 | |
|---|---|---|
| Chiffre d'affaires | 1,21 M | - |
| Bénéfice brut | 446,64 k | - |
| Bénéfice net | -6,54 M | - |
| EBITDA | -6,2 M | - |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 68,95 k € |
Nombre d'actions | 189,51 k |
Plus haut/bas sur 52 semaines | 442,61 € - 0,35 € |
| Dividendes | Non |
Bêta | -0,04 |
Ratio P/E | 0,01 |
Ratio PEG | 0,00 |
Ratio P/B | 0,00 |
Ratio P/S | 0,03 |
Profil de l'entreprise
| Nom | NEWGENIVF GROUP LTD. |
| PDG | Wing Fung Siu |
| Employés | 87 |
Découvrir des actifs
Les actionnaires de NEWGENIVF GROUP LTD. investissent également dans les actifs suivants







